SCHEMBL26000651

SCHEMBL26000651

CC(C)(C)c1ccc2oc3cc4c(cc3c2c1)C(C)(C)CCC4(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PON1 P27169 1/20 0.40
▸ RXRA P19793 5/20 0.37
▸ RXRB P28702 3/20 0.37
▸ ALDH1A1 P00352 2/20 0.34
▸ MAPT P10636 1/20 0.34
▸ CYP26A1 O43174 3/20 0.34
▸ CYP26B1 Q9NR63 2/20 0.34
▸ RARB P10826 4/20 0.31
▸ RARG P13631 4/20 0.31
▸ RXRG P48443 2/20 0.31
▸ KIF11 P52732 1/20 0.31
▸ RARA P10276 3/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ PGR P06401 1/20 0.31
▸ CYP3A4 P08684 1/20 0.31
▸ ADORA3 P0DMS8 1/20 0.31
▸ TBXA2R P21731 1/20 0.31
▸ BLVRB P30043 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ AHR P35869 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26000649 0.91 RXRA (0.37) PON1RXRARXRBALDH1A1MAPT
SCHEMBL26000661 0.82 PON1 (0.32) PON1ALDH1A1MAPTKIF11HPGD
SCHEMBL31069376 0.80 ALDH1A1 (0.33) RXRAALDH1A1MAPTCYP26A1CYP26B1
SCHEMBL23439063 0.80 ALDH1A1 (0.33) RXRAALDH1A1MAPTCYP26A1CYP26B1
SCHEMBL16806203 0.80 PON1 (0.51) PON1ALDH1A1MAPTKIF11MEN1
SCHEMBL23056731 0.80 PON1 (0.54) PON1ALDH1A1MAPTKIF11MEN1
SCHEMBL23439057 0.80 CYP26A1 (0.39) PON1RXRARXRBALDH1A1MAPT
SCHEMBL23439495 0.80 RXRA (0.33) PON1RXRARXRBCYP26A1CYP26B1
SCHEMBL23422190 0.80 CYP26A1 (0.38) PON1RXRAALDH1A1CYP26A1CYP26B1
SCHEMBL26004010 0.78 RXRA (0.33) RXRARXRBCYP26A1CYP26B1RXRG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11807616-B2 Organic compound, and electronic element and electronic device using same SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-11-07 — — US disclosed
US-20230265063-A1 ORGANIC COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-08-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230265063-A1 ORGANIC COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME PIEZO1, OR10J3, OR51E2 PON1 2393/4885RXRA 2012/4885RXRB 2635/4885
US-11807616-B2 Organic compound, and electronic element and electronic device using same PIEZO1, OR10J3, OR51E2 PON1 2393/4885RXRA 2012/4885RXRB 2635/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback